Home  »  Technologies   »  Buy, Sell Or Hold Bone Biologics Corporation (NASD...

Buy, Sell Or Hold Bone Biologics Corporation (NASDAQ:BBLG) At $0.28?

In last trading session, Bone Biologics Corporation (NASDAQ:BBLG) saw 0.16 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.28 trading at $0.01 or 4.52% at ring of the bell on the day assigns it a market valuation of $4.33M. That closing price of BBLG’s stock is at a discount of -2321.43% from its 52-week high price of $6.78 and is indicating a premium of 10.71% from its 52-week low price of $0.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.26 million shares which gives us an average trading volume of 239.07K if we extend that period to 3-months.

Bone Biologics Corporation (NASDAQ:BBLG) trade information

Upright in the green during last session for gaining 4.52%, in the last five days BBLG remained trading in the red while hitting it’s week-highest on Thursday, 11/17/22 when the stock touched $0.28 price level, adding 16.14% to its value on the day. Bone Biologics Corporation’s shares saw a change of -92.05% in year-to-date performance and have moved -16.17% in past 5-day. Bone Biologics Corporation (NASDAQ:BBLG) showed a performance of -42.87% in past 30-days. Number of shares sold short was 61020.0 shares which calculate 0.23 days to cover the short interests.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Bone Biologics Corporation (BBLG) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 54.00% during past 5 years.

BBLG Dividends

Bone Biologics Corporation is more likely to be releasing its next quarterly report in December and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Bone Biologics Corporation (NASDAQ:BBLG)’s Major holders

Insiders are in possession of 54.37% of company’s total shares while institution are holding 5.62 percent of that, with stock having share float percentage of 12.31%. Investors also watch the number of corporate investors in a company very closely, which is 5.62% institutions for Bone Biologics Corporation that are currently holding shares of the company. Vanguard Group, Inc. (The) is the top institutional holder at BBLG for having 33461.0 shares of worth $46845.0. And as of Jun 29, 2022, it was holding 0.32% of the company’s outstanding shares.

The second largest institutional holder is UBS Group AG, which was holding about 7673.0 shares on Jun 29, 2022. The number of shares represents firm’s hold over 0.07% of outstanding shares, having a total worth of $10742.0.

On the other hand, Vanguard Total Stock Market Index Fund and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 33461.0 shares of worth $46845.0 or 0.32% of the total outstanding shares. The later fund manager was in possession of 5900.0 shares on Jun 29, 2022, making its stake of worth around $8260.0 in the company or a holder of 0.06% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]